Home › Alopecia Areata
Pag-aaral pangklinika para sa Alopecia Areata na nagre-recruit sa U.S.
17 pag-aaral para sa Alopecia Areata ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Indianapolis, IN7 pag-aaral
- San Antonio, TX6 pag-aaral
- Miami, FL6 pag-aaral
- Omaha, NE5 pag-aaral
- New York City, NY4 pag-aaral
- Los Angeles, CA3 pag-aaral
- Troy, MI3 pag-aaral
- Spokane, WA3 pag-aaral
- Houston, TX3 pag-aaral
- Portland, OR3 pag-aaral
- Columbus, OH3 pag-aaral
- Irvine, CA3 pag-aaral
Ayos sa estado
- California10 pag-aaral
- Florida8 pag-aaral
- Illinois3 pag-aaral
- Indiana8 pag-aaral
- Maryland5 pag-aaral
- Massachusetts4 pag-aaral
- Michigan5 pag-aaral
- Nebraska5 pag-aaral
- New York6 pag-aaral
- North Carolina3 pag-aaral
- Ohio6 pag-aaral
- Oregon3 pag-aaral
- Pennsylvania3 pag-aaral
- South Carolina3 pag-aaral
- Texas7 pag-aaral
- Washington4 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
Nagre-recruitPhase 2
Edad 18 hanggang 50 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07533006A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT06873945A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
Nagre-recruitPhase 3
Edad 6 hanggang 17 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07772492HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata
Nagre-recruitPhase 1
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07049328A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT07733765Dupilumab in the Treatment of Pediatric Alopecia Areata
Nagre-recruitPhase 2
Edad 6 hanggang 17 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT05866562CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry
Nagre-recruitObservasyonal na pag-aaral
Edad 12 hanggang 17 · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT06562270A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
Nagre-recruitPhase 3
Edad 12 hanggang 63 · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT06012240Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hun 26, 2026 · NCT06747611Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
Edad 12 hanggang 75 · Lahat ng kasarian · Na-update Hun 22, 2026 · NCT05398809Regeneron AA Multicenter (Dupilumab)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 17, 2026 · NCT05551793A Study of LAD603 in Adults With Alopecia Areata
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update May 20, 2026 · NCT07311564A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
Nagre-recruitPhase 3
Edad 6 hanggang 14 · Lahat ng kasarian · Na-update Abr 28, 2026 · NCT07029828A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata
Nagre-recruitPhase 1/2
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Mar 4, 2026 · NCT06826196CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 9, 2026 · NCT05745389Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
Nagre-recruitPhase 2
Edad 12 pataas · Lahat ng kasarian · Na-update Peb 2, 2026 · NCT07242638Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Nagre-recruitPhase 3
Edad 12 hanggang 17 · Lahat ng kasarian · Na-update Ene 28, 2026 · NCT07133308Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.